(Q33965600)

30 July 2017

title

In vitro evidence that subcutaneous administration of glatiramer acetate induces hyporesponsive T cells in patients with multiple sclerosis (English)

1 reference

30 July 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/S1521-6616(03)00020-2

26 December 2023

5

Hafler DA

1 reference

30 July 2017

M. Schmied

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706402

26 December 2023

P. W. Duda

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706402

26 December 2023

J. I. Krieger

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706402

26 December 2023

C. Trollmo

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706402

26 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12706402

26 December 2023

publication date

1 March 2003

1 reference

full work available at URL

30 July 2017

https://api.elsevier.com/content/article/PII:S1521661603000202?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S1521-6616(03)00020-2

https://api.elsevier.com/content/article/PII:S1521661603000202?httpAccept=text/plain

26 December 2023

1 reference

DOI

https://api.crossref.org/works/10.1016/S1521-6616(03)00020-2

26 December 2023

1 reference

30 July 2017

volume

106

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

163-174

1 reference

Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Synthetic copolymer 1 inhibits human T-cell lines specific for myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Synthetic copolymer 1 and myelin basic protein do not require processing prior to binding to class II major histocompatibility complex molecules on living antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Binding of random copolymers of three amino acids to class II MHC molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Binding of copolymer 1 and myelin basic protein leads to clustering of class II MHC molecules on antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Immunogenic potentials of copolymer I in normal human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Treatment with glatiramer acetate induces specific IgG4 antibodies in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Mechanisms of immunomodulation by glatiramer acetate

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Glatiramer acetate (copolymer-1)-specific, human T cell lines: cytokine profile and suppression of T cell lines reactive against myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Characterization of T cell lines derived from glatiramer-acetate-treated multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Early signaling defects in human T cells anergized by T cell presentation of autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Mechanisms of central and peripheral T-cell tolerance: lessons from experimental models of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Systemic antigen in the treatment of T-cell-mediated autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Limiting dilution analysis of the specificity of influenza-immune cytotoxic T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

T Cell Reactivity to MHC Molecules: Immunity Versus Tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Anergic T cells act as suppressor cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Homeostasis and self-tolerance in the immune system: turning lymphocytes off.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Reversal of in vitro T cell clonal anergy by IL-2 stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Biochemical features of anergic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

A cell culture model for T lymphocyte clonal anergy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

1 reference

7 January 2021

Glatiramer acetate (GA) induces IL-13/IL-5 secretion in naive T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Th2 cell clonal anergy as a consequence of partial activation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900020-2

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference